"the TDI of 1 mg/kg b.w./day" has been replaced by "the TDI of 1 µg/kg b.w./day". At low doses decreased feed intake seems to be attributable to the stimulation of the synthesis of pro-inflammatory cytokines under practical conditions, whilst at higher concentrations vomiting is triggered by the interaction of DON with serotonergic and dopaminergic receptors. Pigs have been identified as the most sensitive animals species regarding these adverse effects. However, at present the available data on exposure via feedingstuffs are incomplete, and no safe intake levels for pigs could be deduced from these data. Following absorption, DON is rapidly metabolised by de-epoxidation and glucuronidation, yielding less toxic products. There is no evidence for teratogenicity and genotoxicity of DON and its metabolites, neither in laboratory animal species nor in target animals. Transfer of DON and its metabolites into edible tissues, milk and eggs is very low. Thus, products of animal origin do not contribute significantly to human exposure.